31 March 2017 : Meta-Analysis
Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic ReviewAlexander Weymann1ABCDEFG*, Anton Sabashnikov23ABCDEFG, Sadeq Ali-Hasan-Al-Saegh4ABCDEFG, Aron-Frederik Popov5ABCDEFG, Seyed Jalil Mirhosseini4ABCDEFG, William L. Baker6ABCDEFG, Mohammadreza Lotfaliani4ABCDEFG, Tong Liu7ABCDEFG, Hamidreza Dehghan8ABCDEFG, Senol Yavuz9ABCDEFG, Michel Pompeu Barros de Oliveira Sá101112ABCDEFG, Jae-Sik Jang13ABCDEFG, Mohamed Zeriouh23ABCDEFG, Lei Meng14ABCDEFG, Fabrizio D’Ascenzo15ABCDEFG, Abhishek J. Deshmukh16ABCDEFG, Guiseppe Biondi-Zoccai1718ABCDEFG, Pascal M. Dohmen1ABCDEFG, Hugh Calkins19ABCDEFG, Integrated Meta-Analysis of Cardiac Cardiac Surgery and Cardiology-Group IMCSC-Group]
Med Sci Monit Basic Res 2017; 23:97-140
BACKGROUND: The pathophysiological mechanism associated with the higher prothrombotic tendency in atrial fibrillation (AF) is complex and multifactorial. However, the role of prothrombotic markers in AF remains inconclusive.
MATERIAL AND METHODS: We conducted a meta-analysis of observational studies evaluating the association of coagulation activation, fibrinolytic, and endothelial function with occurrence of AF and clinical adverse events. A comprehensive subgroup analysis and meta-regression was performed to explore potential sources of heterogeneity.
RESULTS: A literature search of major databases retrieved 1703 studies. After screening, a total of 71 studies were identified. Pooled analysis showed the association of coagulation markers (D-dimer (weighted mean difference (WMD) =197.67 and p<0.001), fibrinogen (WMD=0.43 and p<0.001), prothrombin fragment 1-2 (WMD=0.53 and p<0.001), antithrombin III (WMD=23.90 and p=0.004), thrombin-antithrombin (WMD=5.47 and p=0.004)); fibrinolytic markers (tissue-type plasminogen activator (t-PA) (WMD=2.13 and p<0.001), plasminogen activator inhibitor (WMD=11.44 and p<0.001), fibrinopeptide-A (WMD=4.13 and p=0.01)); and endothelial markers (von Willebrand factor (WMD=27.01 and p<0.001) and soluble thrombomodulin (WMD=3.92 and p<0.001)) with AF.
CONCLUSIONS: The levels of coagulation, fibrinolytic, and endothelial markers have been reported to be significantly higher in AF patients than in SR patients.
Keywords: Atrial Fibrillation, Blood Coagulation Disorders, Fibrinolysis
Most Viewed Current Articles
13 Apr 2020 : Original articleOutcome of 24 Weeks of Combined Schroth and Pilates Exercises on Cobb Angle, Angle of Trunk Rotation, Chest...
Med Sci Monit Basic Res 2020; 26:e920449
11 May 2020 : Original articleAnalysis of Psychological and Sleep Status and Exercise Rehabilitation of Front-Line Clinical Staff in the ...
Med Sci Monit Basic Res 2020; 26:e924085
05 Jan 2021 : Review articleA Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against...
Med Sci Monit Basic Res 2021; 27:e929207
10 Aug 2020 : Clinical ResearchEffects of Cognitive Task Training on Dynamic Balance and Gait of Patients with Stroke: A Preliminary Rando...
Med Sci Monit Basic Res 2020; 26:e925264